Related Experiment Video
Updated: Oct 16, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Structure-Activity Relationship of USP5 Inhibitors
Mandeep K Mann1,2, Carlos A Zepeda-Velázquez3, Héctor González-Álvarez2,3
1Structural Genomics Consortium, University of Toronto, 101 College Street, MaRS South Tower, Suite 700, Toronto, Ontario M5G 1L7, Canada.
Researchers developed a novel chemical probe targeting USP5 (an enzyme linked to diseases like cancer). This probe inhibits USP5 activity by binding to its ubiquitin-binding domain, offering a new tool to study the enzyme
Area of Science:
- Biochemistry
- Chemical Biology
- Enzymology
Background:
- Ubiquitin-specific protease 5 (USP5) is a deubiquitinase implicated in various diseases, notably cancer.
- Currently, no specific chemical probes exist to target USP5.
- USP5 possesses a poorly characterized zinc-finger ubiquitin-binding domain (ZnF-UBD) crucial for its function.
Purpose of the Study:
- To develop a chemical probe targeting the USP5 ZnF-UBD.
- To inhibit USP5 catalytic activity through targeted binding.
- To establish a chemical and structural foundation for future USP5 research.
Main Methods:
- Structure-activity relationship (SAR) studies of a chemical series targeting the USP5 ZnF-UBD.
- Crystallographic characterization of the ZnF-UBD in complex with various ligands.
- Biochemical assays to assess binding affinity (KD) and inhibitory activity.
Main Results:
- Identification of compound 64, which binds the USP5 ZnF-UBD with a KD of 2.8 μM.
- Compound 64 demonstrated selectivity over nine other proteins with similar ZnF-UBD domains.
- Compound 64 inhibited USP5's catalytic cleavage of di-ubiquitin in vitro.
Conclusions:
- A chemical series was developed that targets the USP5 ZnF-UBD and inhibits enzyme activity.
- Compound 64 represents a selective inhibitor and a valuable starting point for a USP5 chemical probe.
- This work provides a framework for future investigations into USP5's cellular roles.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....